These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14862109)

  • 21. [Cerebrospinal fluid during streptomycin therapy of tuberculous meningitis].
    BAPTISTA dos REIS J; BEI A
    An Paul Med Cir; 1951 Mar; 61(3):204-10. PubMed ID: 14829821
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cerebrospinal fluid in the course of tuberculous meningitis during streptomycin therapy].
    dos REIS JB; BEI A
    Rev Paul Med; 1951 Jan; 38(1):64-8. PubMed ID: 14816797
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE CEREBROSPINAL FLUID IN TUBERCULOUS MENINGITIS].
    BURDACH R; MAFFIOLETTI F; PALACIOS E
    Pediatria (Santiago); 1963; 6():171-7. PubMed ID: 14080017
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of abnormal cerebrospinal fluid pressure to influence cerebral function.
    RYDER HW; ROSENAUER A; PENKA EJ; ESPEY FF; EVANS JP
    AMA Arch Neurol Psychiatry; 1953 Nov; 70(5):563-86. PubMed ID: 13091505
    [No Abstract]   [Full Text] [Related]  

  • 25. Contribution to the physiopathology of the cerebrospinal fluid. I. Residual nitrogen in cerebrospinal fluid during tuberculous meningitis treated with streptomycin.
    CALANDI C; PERITI P
    Riv Clin Pediatr; 1953 Aug; 52(2):87-99. PubMed ID: 13121870
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnostic and prognostic significance of cerebrospinal fluid changes, particularly of the sugar and chloride levels, in tuberculous meningitis treated with streptomycin and in some cases with PAS].
    GWALTER H; PULVER W
    Schweiz Med Wochenschr; 1951 Jul; 81(27):637-9. PubMed ID: 14866054
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytological and chemical changes in the cerebrospinal fluid during streptomycin therapy of tuberculous meningitis].
    KUKOLEWSKA J
    Pediatr Pol; 1952 Dec; 27(12):1381-96. PubMed ID: 13046939
    [No Abstract]   [Full Text] [Related]  

  • 28. [Relation between the circulation of juice of nasal mucosa and the cranial cavity or cerebrospinal fluid].
    KROMPECHER I; FORNET B; FOLDES I; HADHAZY C; OROSZ A; KOSA C; TOTH G; HANKISS J; FILIPP G; KOVER B; KECSKES J
    Acta Physiol Acad Sci Hung; 1954; Suppl. 6():56-8. PubMed ID: 14375986
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cyto-chemical considerations on modifications in the cerebrospinal fluid following therapy of tuberculous meningitis with streptomycin with special reference to glycorrhachia and chlorurorrhachia].
    CIULLI G; SPADARI W
    Friuli Med; 1953; 8(1):5-24. PubMed ID: 13043696
    [No Abstract]   [Full Text] [Related]  

  • 30. [Streptomycin resistance of Mycobacterium tuberculosis cultured in cerebro-spinal fluid].
    KWAPINSKI J
    Gruzlica (1926); 1950; 18(3-4):437-47. PubMed ID: 14823454
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neurolytic effects of normal and post-shock cerebrospinal fluid].
    PUCA A; LAMPITELLA P
    Rass Neuropsichiatr; 1951; 5(4):244-7. PubMed ID: 13177965
    [No Abstract]   [Full Text] [Related]  

  • 32. The origin of the pre-albumin in the cerebrospinal-fluid.
    BOOIJ J
    Folia Psychiatr Neurol Neurochir Neerl; 1958; 61(2):84-90. PubMed ID: 13586405
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of cerebrospinal fluid formation and resorption following blunt injury of the brain].
    REIMERS C; NEUDECK J
    Dtsch Z Nervenheilkd; 1950; 164(5-6):509-24. PubMed ID: 14802173
    [No Abstract]   [Full Text] [Related]  

  • 34. Passage of barbital into cerebrospinal fluid.
    MARK LC; BRAND L; DAYTON PG; TALLER D; PAPPER EM
    Proc Soc Exp Biol Med; 1960 Mar; 103():606-8. PubMed ID: 14421232
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of streptomycin concentration in the spinal fluid in tuberculous meningitis].
    HANSSEN P; LERCHE C
    Nord Med; 1950 Mar; 43(10):430-1. PubMed ID: 14780452
    [No Abstract]   [Full Text] [Related]  

  • 36. The actions of substances introduced into the cerebrospinal fluid and the problem of intracranial chemoreceptors.
    WINTERSTEIN H
    Pharmacol Rev; 1961 Mar; 13():71-107. PubMed ID: 13785960
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of dehydration on cerebrospinal fluid formation and flow.
    SMITH HS; BERING EA; INGRAHAM FD
    Trans Am Neurol Assoc; 1960; 85():233-4. PubMed ID: 13914260
    [No Abstract]   [Full Text] [Related]  

  • 38. [Streptomycin levels in cerebrospinal fluid in relation to possible enzyme action or changes in meningeal permeability during therapy of meningeal tuberculosis].
    PANI A
    Minerva Med; 1953 May; 44(41):1361-8. PubMed ID: 13072057
    [No Abstract]   [Full Text] [Related]  

  • 39. [On non-symptomatic phases of the CSF in streptomycin therapy of tuberculous meningitis].
    MULLER D
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 108(5):418-28. PubMed ID: 13081555
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the rôle of the cerebrospinal fluid in brain metabolism as measured with radioactive phosphate.
    BAKAY L; LINDBERG O
    Acta Physiol Scand; 1949 Mar; 17(2-3):179-90. PubMed ID: 18149750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.